Description
ECO-RESET: A Phase 2B, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose, Multicenter Study to Assess Efficacy and Safety of SER-287 in Adults With Active Mild-to-Moderate Ulcerative Colitis
Location: PAMF (Peninsula/South Bay)
Please contact: Elizabeth Jameiro jameire@sutterhealth.org about study SERES 201
View study details on ClinicalTrials.gov
Principal Investigator
Co-Investigator(s)
Recruitment Status
Active, Recruiting
Start Date
May 10, 2019
Related Studies
Transforming Primary and Specialty Care for Inflammatory Bowel Disease
Use healthcare data to personalize the healthcare experience for people with inflammatory
bowel disease.
Investigator(s): Alice R. Pressman, Ph.D., M.S.